Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 3
introduction of cytarabine and daunorubicin liposome antineoplastic into central vein, percutaneous approach, new technology group 3
New Technology @ Anatomical Regions @ Introduction @ Central Vein @ Percutaneous @ Cytarabine and Daunorubicin Liposome Antineoplastic @ New Technology Group 3
new technology @ anatomical regions @ introduction @ central vein @ percutaneous @ cytarabine and daunorubicin liposome antineoplastic @ new technology group 3